Loading…

Adenoviral transduction of a cytosine deaminase/thymidine kinase fusion gene into prostate carcinoma cells enhances prodrug and radiation sensitivity

Prostate tumor cells (PC‐3) were transduced with defective, recombinant adenovirus containing a fusion gene encoding the Escherichia coli cytosine deaminase and herpes simplex virus type‐1 thymidine kinase under the control of a cytomegalovirus promoter. Expression levels of the fusion protein were...

Full description

Saved in:
Bibliographic Details
Published in:International journal of cancer 1999-07, Vol.82 (2), p.293-297
Main Authors: Blackburn, Robert V., Galoforo, Sandra S., Corry, Peter M., Lee, Yong J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c3432-41d5cba78d5b5e306605fd27de89f217b471d14040db11c80c401d93550726f13
container_end_page 297
container_issue 2
container_start_page 293
container_title International journal of cancer
container_volume 82
creator Blackburn, Robert V.
Galoforo, Sandra S.
Corry, Peter M.
Lee, Yong J.
description Prostate tumor cells (PC‐3) were transduced with defective, recombinant adenovirus containing a fusion gene encoding the Escherichia coli cytosine deaminase and herpes simplex virus type‐1 thymidine kinase under the control of a cytomegalovirus promoter. Expression levels of the fusion protein were dependent on the multiplicity of infection used and incubation time following infection. PC‐3 cells expressing this protein were sensitized to killing by the normally innocuous prodrugs 5‐fluorocytosine and ganciclovir. In addition, radiation‐induced killing was enhanced in virally infected cells in the presence of the prodrugs. Int. J. Cancer 82:293–297, 1999. © 1999 Wiley‐Liss, Inc.
doi_str_mv 10.1002/(SICI)1097-0215(19990719)82:2<293::AID-IJC22>3.0.CO;2-H
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17307576</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17307576</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3432-41d5cba78d5b5e306605fd27de89f217b471d14040db11c80c401d93550726f13</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhSMEotPCKyAvEGoXmV7bSZxMEWgUfiao0iwAwc7y2E5rSJwSO63yILwvzmT4kUBCXlg6-nx87j1R9BLDEgOQ89P3VVmdYShYDASnp7goCmC4OMvJijwnBV2t1tWruHpXEvKCLmFZbi9IvLkXLX69uR8tghPEDNPsKDp27gsAxikkD6MjDDQvWJYtou9rpW13a3rRIN8L69Qgveks6mokkBx954zVSGnRGiucPvfXY2vUpH3dC6ge3MRf6SAZ6zt003fOC6-RFL00tmuDj24ah7S9FlZqNxGqH66QsAr1Qhmx_9Fp64w3t8aPj6IHtWicfny4T6KPb15_KDfx5fZtVa4vY0kTSuIEq1TuBMtVuks1hSyDtFaEKZ0XNcFslzCscAIJqB3GMgeZAFYFTVNgJKsxPYmezb4h0bdBO89b46awwupucBwzCixlWQA_zaAMw7le1_ymN63oR46BT41xPjXGp-3zafv8Z2M8JzycgnIeGuP7xjjlwMtt0DfB-ckhwrBrtfrDd64oAE8PgHBSNHUoSRr3m8tZkpIkYJ9n7M40evwr3n_T_SvcLNAfIRDBUA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17307576</pqid></control><display><type>article</type><title>Adenoviral transduction of a cytosine deaminase/thymidine kinase fusion gene into prostate carcinoma cells enhances prodrug and radiation sensitivity</title><source>Wiley</source><creator>Blackburn, Robert V. ; Galoforo, Sandra S. ; Corry, Peter M. ; Lee, Yong J.</creator><creatorcontrib>Blackburn, Robert V. ; Galoforo, Sandra S. ; Corry, Peter M. ; Lee, Yong J.</creatorcontrib><description>Prostate tumor cells (PC‐3) were transduced with defective, recombinant adenovirus containing a fusion gene encoding the Escherichia coli cytosine deaminase and herpes simplex virus type‐1 thymidine kinase under the control of a cytomegalovirus promoter. Expression levels of the fusion protein were dependent on the multiplicity of infection used and incubation time following infection. PC‐3 cells expressing this protein were sensitized to killing by the normally innocuous prodrugs 5‐fluorocytosine and ganciclovir. In addition, radiation‐induced killing was enhanced in virally infected cells in the presence of the prodrugs. Int. J. Cancer 82:293–297, 1999. © 1999 Wiley‐Liss, Inc.</description><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/(SICI)1097-0215(19990719)82:2&lt;293::AID-IJC22&gt;3.0.CO;2-H</identifier><identifier>PMID: 10389766</identifier><identifier>CODEN: IJCNAW</identifier><language>eng</language><publisher>New York: John Wiley &amp; Sons, Inc</publisher><subject>Adenoviridae - genetics ; Animals ; Antimetabolites - pharmacology ; Antimetabolites, Antineoplastic - pharmacology ; Antiviral Agents - pharmacology ; Biological and medical sciences ; Biotechnology ; Carcinoma - pathology ; Carcinoma - radiotherapy ; Carcinoma - therapy ; Cytomegalovirus - genetics ; Cytosine Deaminase ; Flucytosine - pharmacology ; Fundamental and applied biological sciences. Psychology ; Ganciclovir - pharmacology ; Gene Expression Regulation, Neoplastic ; Gene Expression Regulation, Viral ; Gene therapy ; Genetic Therapy ; Genetic Vectors - genetics ; Health. Pharmaceutical industry ; Humans ; Industrial applications and implications. Economical aspects ; Male ; Nucleoside Deaminases - genetics ; Prodrugs - pharmacology ; Promoter Regions, Genetic ; Prostatic Neoplasms - pathology ; Prostatic Neoplasms - radiotherapy ; Prostatic Neoplasms - therapy ; Radiation Tolerance - drug effects ; Radiation Tolerance - genetics ; Rats ; Recombinant Fusion Proteins - genetics ; Recombinant Fusion Proteins - metabolism ; Thymidine Kinase - genetics ; Tumor Cells, Cultured - drug effects ; Tumor Cells, Cultured - radiation effects</subject><ispartof>International journal of cancer, 1999-07, Vol.82 (2), p.293-297</ispartof><rights>Copyright © 1999 Wiley‐Liss, Inc.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3432-41d5cba78d5b5e306605fd27de89f217b471d14040db11c80c401d93550726f13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1874524$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10389766$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Blackburn, Robert V.</creatorcontrib><creatorcontrib>Galoforo, Sandra S.</creatorcontrib><creatorcontrib>Corry, Peter M.</creatorcontrib><creatorcontrib>Lee, Yong J.</creatorcontrib><title>Adenoviral transduction of a cytosine deaminase/thymidine kinase fusion gene into prostate carcinoma cells enhances prodrug and radiation sensitivity</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>Prostate tumor cells (PC‐3) were transduced with defective, recombinant adenovirus containing a fusion gene encoding the Escherichia coli cytosine deaminase and herpes simplex virus type‐1 thymidine kinase under the control of a cytomegalovirus promoter. Expression levels of the fusion protein were dependent on the multiplicity of infection used and incubation time following infection. PC‐3 cells expressing this protein were sensitized to killing by the normally innocuous prodrugs 5‐fluorocytosine and ganciclovir. In addition, radiation‐induced killing was enhanced in virally infected cells in the presence of the prodrugs. Int. J. Cancer 82:293–297, 1999. © 1999 Wiley‐Liss, Inc.</description><subject>Adenoviridae - genetics</subject><subject>Animals</subject><subject>Antimetabolites - pharmacology</subject><subject>Antimetabolites, Antineoplastic - pharmacology</subject><subject>Antiviral Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Biotechnology</subject><subject>Carcinoma - pathology</subject><subject>Carcinoma - radiotherapy</subject><subject>Carcinoma - therapy</subject><subject>Cytomegalovirus - genetics</subject><subject>Cytosine Deaminase</subject><subject>Flucytosine - pharmacology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Ganciclovir - pharmacology</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Gene Expression Regulation, Viral</subject><subject>Gene therapy</subject><subject>Genetic Therapy</subject><subject>Genetic Vectors - genetics</subject><subject>Health. Pharmaceutical industry</subject><subject>Humans</subject><subject>Industrial applications and implications. Economical aspects</subject><subject>Male</subject><subject>Nucleoside Deaminases - genetics</subject><subject>Prodrugs - pharmacology</subject><subject>Promoter Regions, Genetic</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Prostatic Neoplasms - radiotherapy</subject><subject>Prostatic Neoplasms - therapy</subject><subject>Radiation Tolerance - drug effects</subject><subject>Radiation Tolerance - genetics</subject><subject>Rats</subject><subject>Recombinant Fusion Proteins - genetics</subject><subject>Recombinant Fusion Proteins - metabolism</subject><subject>Thymidine Kinase - genetics</subject><subject>Tumor Cells, Cultured - drug effects</subject><subject>Tumor Cells, Cultured - radiation effects</subject><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqFkc1u1DAUhSMEotPCKyAvEGoXmV7bSZxMEWgUfiao0iwAwc7y2E5rSJwSO63yILwvzmT4kUBCXlg6-nx87j1R9BLDEgOQ89P3VVmdYShYDASnp7goCmC4OMvJijwnBV2t1tWruHpXEvKCLmFZbi9IvLkXLX69uR8tghPEDNPsKDp27gsAxikkD6MjDDQvWJYtou9rpW13a3rRIN8L69Qgveks6mokkBx954zVSGnRGiucPvfXY2vUpH3dC6ge3MRf6SAZ6zt003fOC6-RFL00tmuDj24ah7S9FlZqNxGqH66QsAr1Qhmx_9Fp64w3t8aPj6IHtWicfny4T6KPb15_KDfx5fZtVa4vY0kTSuIEq1TuBMtVuks1hSyDtFaEKZ0XNcFslzCscAIJqB3GMgeZAFYFTVNgJKsxPYmezb4h0bdBO89b46awwupucBwzCixlWQA_zaAMw7le1_ymN63oR46BT41xPjXGp-3zafv8Z2M8JzycgnIeGuP7xjjlwMtt0DfB-ckhwrBrtfrDd64oAE8PgHBSNHUoSRr3m8tZkpIkYJ9n7M40evwr3n_T_SvcLNAfIRDBUA</recordid><startdate>19990719</startdate><enddate>19990719</enddate><creator>Blackburn, Robert V.</creator><creator>Galoforo, Sandra S.</creator><creator>Corry, Peter M.</creator><creator>Lee, Yong J.</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>19990719</creationdate><title>Adenoviral transduction of a cytosine deaminase/thymidine kinase fusion gene into prostate carcinoma cells enhances prodrug and radiation sensitivity</title><author>Blackburn, Robert V. ; Galoforo, Sandra S. ; Corry, Peter M. ; Lee, Yong J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3432-41d5cba78d5b5e306605fd27de89f217b471d14040db11c80c401d93550726f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adenoviridae - genetics</topic><topic>Animals</topic><topic>Antimetabolites - pharmacology</topic><topic>Antimetabolites, Antineoplastic - pharmacology</topic><topic>Antiviral Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Biotechnology</topic><topic>Carcinoma - pathology</topic><topic>Carcinoma - radiotherapy</topic><topic>Carcinoma - therapy</topic><topic>Cytomegalovirus - genetics</topic><topic>Cytosine Deaminase</topic><topic>Flucytosine - pharmacology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Ganciclovir - pharmacology</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Gene Expression Regulation, Viral</topic><topic>Gene therapy</topic><topic>Genetic Therapy</topic><topic>Genetic Vectors - genetics</topic><topic>Health. Pharmaceutical industry</topic><topic>Humans</topic><topic>Industrial applications and implications. Economical aspects</topic><topic>Male</topic><topic>Nucleoside Deaminases - genetics</topic><topic>Prodrugs - pharmacology</topic><topic>Promoter Regions, Genetic</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Prostatic Neoplasms - radiotherapy</topic><topic>Prostatic Neoplasms - therapy</topic><topic>Radiation Tolerance - drug effects</topic><topic>Radiation Tolerance - genetics</topic><topic>Rats</topic><topic>Recombinant Fusion Proteins - genetics</topic><topic>Recombinant Fusion Proteins - metabolism</topic><topic>Thymidine Kinase - genetics</topic><topic>Tumor Cells, Cultured - drug effects</topic><topic>Tumor Cells, Cultured - radiation effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Blackburn, Robert V.</creatorcontrib><creatorcontrib>Galoforo, Sandra S.</creatorcontrib><creatorcontrib>Corry, Peter M.</creatorcontrib><creatorcontrib>Lee, Yong J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Blackburn, Robert V.</au><au>Galoforo, Sandra S.</au><au>Corry, Peter M.</au><au>Lee, Yong J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adenoviral transduction of a cytosine deaminase/thymidine kinase fusion gene into prostate carcinoma cells enhances prodrug and radiation sensitivity</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>1999-07-19</date><risdate>1999</risdate><volume>82</volume><issue>2</issue><spage>293</spage><epage>297</epage><pages>293-297</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><coden>IJCNAW</coden><abstract>Prostate tumor cells (PC‐3) were transduced with defective, recombinant adenovirus containing a fusion gene encoding the Escherichia coli cytosine deaminase and herpes simplex virus type‐1 thymidine kinase under the control of a cytomegalovirus promoter. Expression levels of the fusion protein were dependent on the multiplicity of infection used and incubation time following infection. PC‐3 cells expressing this protein were sensitized to killing by the normally innocuous prodrugs 5‐fluorocytosine and ganciclovir. In addition, radiation‐induced killing was enhanced in virally infected cells in the presence of the prodrugs. Int. J. Cancer 82:293–297, 1999. © 1999 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>10389766</pmid><doi>10.1002/(SICI)1097-0215(19990719)82:2&lt;293::AID-IJC22&gt;3.0.CO;2-H</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0020-7136
ispartof International journal of cancer, 1999-07, Vol.82 (2), p.293-297
issn 0020-7136
1097-0215
language eng
recordid cdi_proquest_miscellaneous_17307576
source Wiley
subjects Adenoviridae - genetics
Animals
Antimetabolites - pharmacology
Antimetabolites, Antineoplastic - pharmacology
Antiviral Agents - pharmacology
Biological and medical sciences
Biotechnology
Carcinoma - pathology
Carcinoma - radiotherapy
Carcinoma - therapy
Cytomegalovirus - genetics
Cytosine Deaminase
Flucytosine - pharmacology
Fundamental and applied biological sciences. Psychology
Ganciclovir - pharmacology
Gene Expression Regulation, Neoplastic
Gene Expression Regulation, Viral
Gene therapy
Genetic Therapy
Genetic Vectors - genetics
Health. Pharmaceutical industry
Humans
Industrial applications and implications. Economical aspects
Male
Nucleoside Deaminases - genetics
Prodrugs - pharmacology
Promoter Regions, Genetic
Prostatic Neoplasms - pathology
Prostatic Neoplasms - radiotherapy
Prostatic Neoplasms - therapy
Radiation Tolerance - drug effects
Radiation Tolerance - genetics
Rats
Recombinant Fusion Proteins - genetics
Recombinant Fusion Proteins - metabolism
Thymidine Kinase - genetics
Tumor Cells, Cultured - drug effects
Tumor Cells, Cultured - radiation effects
title Adenoviral transduction of a cytosine deaminase/thymidine kinase fusion gene into prostate carcinoma cells enhances prodrug and radiation sensitivity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T02%3A13%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adenoviral%20transduction%20of%20a%20cytosine%20deaminase/thymidine%20kinase%20fusion%20gene%20into%20prostate%20carcinoma%20cells%20enhances%20prodrug%20and%20radiation%20sensitivity&rft.jtitle=International%20journal%20of%20cancer&rft.au=Blackburn,%20Robert%20V.&rft.date=1999-07-19&rft.volume=82&rft.issue=2&rft.spage=293&rft.epage=297&rft.pages=293-297&rft.issn=0020-7136&rft.eissn=1097-0215&rft.coden=IJCNAW&rft_id=info:doi/10.1002/(SICI)1097-0215(19990719)82:2%3C293::AID-IJC22%3E3.0.CO;2-H&rft_dat=%3Cproquest_cross%3E17307576%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3432-41d5cba78d5b5e306605fd27de89f217b471d14040db11c80c401d93550726f13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17307576&rft_id=info:pmid/10389766&rfr_iscdi=true